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Abstract 
Quantitatively determining the skin concentration-distance profiles of topically applied drugs is important 
for evaluating their safety and efficacy. The aim of the present study was to quantitatively visualize the 
distribution of hydrophilic drugs through the skin using confocal laser scanning microscopy (CLSM) in order 
to obtain skin concentration-distance profiles. FITC-dextran with a molecular weight of approximately 4 
kDa (FD-4) was selected as the model fluorescent drug in the present study, and excised pig ear skin was 
used. The skin concentration of FD-4 at each depth of a skin section was assessed by imaging analysis of 
the intensity of fluorescence. The FD-4 skin concentration-distance profile obtained was analyzed using 
Fick’s second law of diffusion, and was markedly similar to that using skin permeation parameters in the 
skin permeation study. These results suggest that the present CLSM method may be a promising tool for 
quantitatively visualizing the concentration-distance profiles of drugs through the skin. 
Keywords 
Confocal microscopy; FITC-dextran, dermatopharmacokinetics, skin permeation 
 
Introduction 
Drug delivery through the skin remains an attractive and challenging area for research and 
development. Most of the drugs contained in transdermal delivery systems are lipophilic with low 
molecular weights. However, various chemical and physical approaches have been used to overcome the 
barrier function of the stratum corneum so that even malabsorptive hydrophilic and high weight molecular 
compounds can diffuse into the deeper regions of the skin. An assessment of the chemical concentrations 
of drugs in the skin is essential for developing topical pharmaceutical products and functional cosmetics; 
therefore, drug disposition in the skin (stratum corneum, viable epidermis/dermis, and appendages) as 
well as the concentration-distance profiles of these compounds through the skin need to be elucidated in 
more detail [1-4]. 
Since the skin, which is a structurally heterogeneous organ, is not uniformly distributed for topically 
applied drugs, it remains unclear how drugs permeate the skin layers from the surface to deeper regions 
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over time. The skin is an extremely thin organ; thus, as a small amount of a drug may result in a high target 
concentration, a sensitive method is needed to determine the drug concentration in each layer of the skin 
after its topical application.  
Several conventional methods, including the suction blister [5], punch and shave biopsy [6], and 
homogenization [7] methods, have been used to measure the concentration of a drug in the skin. 
However, these methods can only measure average drug concentrations in the total area of excised whole 
skin instead of those at each depth of the skin. Furthermore, these methods cannot provide a visual 
observation of drug disposition from the surface to deeper regions of the skin, which is necessary for 
further understanding of the dermatopharmacokinetics of topically applied drugs. The tape-stripping 
method [8-12] has been used to measure drug concentrations at each depth of the skin, but only in the 
stratum corneum. A clearer understanding of drug disposition through the whole skin will be helpful for 
evaluating their safety and efficacy by specifying the skin tissue targeted by these drugs. 
However, the drug concentration at each depth of the skin has been predicted using various 
mathematical equations [13-18]. We previously reported that the cutaneous disposition of topically 
applied drugs could be predicted using the difference method based on Fick’s 2nd law of diffusion, and also 
that the average drug concentration in the stratum corneum and viable epidermis/dermis could be 
determined separately [19-22]. However, Fick’s law-based approach requires a relatively advanced 
knowledge of mathematical equations in order to estimate the cutaneous disposition of topically applied 
drugs. 
 
Figure 1.  Chemical structure of FD-4 
 
Therefore, the aim of the present study was to develop a quantitative, visual, simple, sensitive, and 
effective method to analysis concentration-distance profile of topically applied compounds using confocal 
laser scanning microscopy (CLSM). The CLSM could be used to quantitatively visualize disposition of 
fluorescent compounds or high molecular weight compounds with fluorescent labeling moiety through the 
skin from the viewpoint of depth. In the present study, the mathematical approach represented by the 
difference equation method based on Fick’s law of diffusion to obtain a concentration-distance profile was 




















































































ADMET & DMPK 2(4) (2014) 221-234 Imaging analysis of topically applied FITC-dextran 
doi: 10.5599/admet.2.4.42 223 
weight of about 4 kDa (FD-4) as a candidate to excised skin from the pig ear in which the stratum corneum 
had been removed by stripping. Dermatodynamics could be closely related to drug concentration in viable 
epidermis and dermis not in the stratum corneum after topical application. Thus, we selected the stripped 
skin to investigate the possibility of quantitative determination of FD-4 concentration in viable epidermis 
and dermis. Concentration-distance profile of FD-4 through the skin was quantified by imaging analysis 
(CLSM) over time. 
Theoretical [22-25] 
Stripped skin excised from the pig ear was assumed to be a homogeneous membrane [26]. The present 
chemical compound permeation study through the skin was performed at an infinite dose under a sink 
condition in the receiver compartment. Figure 2 illustrates the typical concentration-distance profile of a 
chemical compound across stripped skin in the present study. 
Membrane 
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Figure  2. Schematic diagram of a concentration-distance profile in stripped pig ear skin (one-layered diffusion 
model) 
 
The concentration of the chemical compound, Cs, in the stripped skin at a position, x, and time, t, was 











                     (1) 
where Ds is the effective diffusion coefficient of the chemical compound in the stripped skin. The initial 
condition (I.C.) and boundary condition (B.C.) in the present study were as follows: 
I.C.      t = 0  0 < x < L  Cs = 0 
B.C.      t > 0  x = 0    Cs = KCv 







  (2) 
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where L is the thickness of the stripped pig ear skin (1000 μm), K is the partition coefficient of the chemical 
compound from the donor solution to the stripped skin, Cv is the chemical compound concentration in the 
donor solution, Vd is the volume of the donor solution, and A is the effective permeation area of the skin. 
The left and right members in Eq. (1) can be expressed by the following difference formulations [27]: 
 , , 1 ,
1i j
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   (4) 
where Cij  is the concentration of the chemical compound at the i-th position and j-th time. Δx is xi+1-xi and 
Δt is tj+1-tj. By substituting Eqs.(3) and (4) into Eq. (1), the following equation was obtained. 
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where r shows ∆t/∆x2.  
The concentration of FD-4 in the stripped pig ear skin was obtained by a curve fitting the cumulative 
amount of FD-4 that permeated through the stripped skin to the theoretical values using a least squares 
method. The least squares calculation was performed using the spreadsheet software MicrosoftⓇ Excel and 
∆t and ∆x were set where Dsr may become 0.5 or less. 
 
Experimental  
Materials and methods 
FD-4 was obtained from Sigma-Aldrich (St. Louis, MO, U.S.A.). The cellophane tape (Packaging tape, 
Series 405) used for tape stripping was obtained from Nichiban Co., Ltd. (Tokyo, Japan). Other reagents and 
solvents were of reagent or HPLC grade and used without further purification. 
Experimental animals 
The edible ears of three yuan pigs were obtained from Saitama Experimental Animals* (Sugito, Saitama, 
Japan). Animal experiments were approved by the Institutional Animal Care and Use Committee of Josai 
University (Sakado, Saitama, Japan). 
Skin extraction and pretreatment 
The skin used in the FD-4 permeation experiment was carefully washed and wiped well with distilled 
water, and the surface of the stratum corneum surface was tape-stripped 50 times using cellophane tape 
to remove the whole layer of the stratum corneum. One thousand-micrometer-thick stripped pig ear skin 
slices were prepared using a dermatome (Acculan 3Ti Dermatome, Aesculap-a B. Braun Company, 
Melsungen, Hessen, Germany) to separate the upper epidermis from the dermis and subcutaneous tissues 
[28]. 
 
                                                     
 
*
 Now, all the business was entrusted to the Tokyo Laboratory Animals (Tokyo, Japan). 
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Preparation of pig ear skin pieces for the calibration of FD-4 concentrations 
To prepare a calibration curve for the quantitative analysis of FD-4, excised stripped pig ear skin pieces 
were cut into an appropriate size and completely immersed in solutions with different concentrations of 
FD-4 (0.05, 0.50, 1.00, 2.50, 4.00, and 5.00 mM). As a control, skin pieces were immersed into pH 7.4 
phosphate-buffered saline (PBS). All skin pieces were removed after 24 hours, embedded in super 
cryoembedding medium (Section-Lab, Hiroshima, Japan), frozen in isopentane cooled with dry ice to  
-20 °C, and then stored at -30 °C before further use. 
Skin section observations using a confocal laser scanning microscope (CLSM) 
Ten-micrometer-thick skin sections were prepared in a vertical direction by a cryostat (CM3050, LEICA, 
Wetzler, Hessen, Germany) using the skin pieces obtained as described in (3.4). The intensity of 
fluorescence was observed in these skin sections by CLSM (Fluoview FV1000 and software: FV10-ASW, 
Olympus, Tokyo, Japan). The CLSM conditions for FD-4 were as follows: wavelength, 473 nm; scan speed, 
200 μs/pix; laser power, 1 %; high voltage, 236 V; gain, 1.125 x; and offset, 0.  
Calculation of fluorescence intensity for FD-4 from CLSM images 
Analysis points (50 points) were selected to calculate the fluorescence intensity for FD-4 from one skin 
section, and an average value was obtained from these points. Figure 3 shows an exemplified plot. The 
intensity of autofluorescence was obtained separately from an image of a skin section immersed in PBS 
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Skin permeation experiments for FD-4 
Stripped skin samples were set in vertical-typed diffusion cells (effective diffusion area: 1.77 cm
2
) with 
the epidermis side facing the donor compartment. PBS (pH 7.4, 1 and 6 mL) was applied to the donor and 
receiver cells, respectively, for 1 h prior to starting the skin permeation experiment in order not only to 
reduce the influence of autofluorescence leaking into the receiver side, but also to hydrate the skin. After 
recovering PBS from the epidermis side, the same volume of 5 mM FD-4 was added to start the 
permeation experiment. Skin permeation experiments were performed at 32 °C over 5 h, and the receiver 
solution was continuously stirred with a star-head-type magnetic stirrer. At the predetermined times, an 
aliquot (0.5 mL) was withdrawn from the receiver cell and the same volume of PBS was added to the 
compartment to keep the volume constant. The concentration of FD-4 in the sample was measured by a 
fluorescence spectrophotometer (RF-5300, Shimadzu Corporation, Kyoto, Japan). 
Determination of FD-4 
The sample solution of FD-4 obtained from the permeation experiment was centrifuged (18,800 ×g, 
4 ˚C, 5 min) and 300 μL of the supernatant was used for determination at excised and fluorescence 
wavelengths of 490 and 520 nm, respectively.  
Skin treatment after the skin permeation experiment for FD-4 
Skin sectioning was only performed after the permeation experiment for FD-4. After the permeation 
experiment, the skin surface was washed three times using 1 mL of PBS on the Franz-type diffusion cell. 
The skin sample taken from the diffusion cell was cut vertically using a razor blade, embedded in super 
cryoembedding medium, and frozen in isopentane cooled with dry ice. Skin slices (10 μm in thickness) 
were made using a cryostat and observed under CLSM. The CLSM conditions have already been described 
above. 
Image analysis of skin sections using CLSM 
Skin section images were obtained by CLSM. Six points under one line were plotted from the epidermis 
side (x = 0) onto these images to calculate the fluorescence intensity. Four lines were then measured to 
determine the intensity of fluorescence. The average intensity of fluorescence was calculated from the 
same depth position of the plot. Figure 4 shows a plotting example. The average fluorescence value at each 
depth was obtained by subtracting the average autofluorescence values. 
Analysis of statistics 
The calibration curve for the concentration of FD-4 in skin sections using CLSM was analyzed by 
Pearson’s correlation coefficient (R2) to determine whether a linear relationship existed between the 
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Figure 4. Example of a CLSM observation image for FD-4 fluorescence intensity in stripped pig ear skin after the 




CLSM observations of pig ear skin sections immersed in solutions with various concentrations of FD-4  
Stripped pig ear skin was observed by CLSM after the application of solutions with different 
concentrations of FD-4. Figure 5 shows CLSM images of pig ear skin sections after their immersion in 
solutions with various concentrations of FD-4. Figure 5g shows the control (the immersed concentration of 
FD-4 is 0). Elevations were observed in the intensity of fluorescence in the image with increases in the 
immersed concentration of FD-4 (Fig. 5a→f). 
 
Calibration curve of FD-4 in skin sections observed by CLSM 
Figure 6 shows a calibration curve of the average intensity of fluorescence due to FD-4 in stripped skin 
as obtained from CLSM images (Fig. 5). A strong correlation (R2=0.99636) was observed between the 
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Figure 5. CLSM images for FD-4 fluorescence intensity in stripped pig ear skin after immersions in solutions with 
different concentrations of FD-4. a) 0.05 mM (0.18 mg/mL), b) 0.5 mM (1.83 mg/mL), c) 1 mM (3.67 μg/mL), d) 2.5 mM 
(9.17 mg/mL), e) 4 mM (14.68 mg/mL), f) 5 mM (18.35 mg/mL), g) 0 mM (control). Dashed line: boundary of the skin 
 











































Figure 6. Relationship between FD-4 fluorescence intensity observed by CLSM and the concentration of FD-4 
applied. Each point shows the mean ± S.D. (n = 50) 
a) b) c) 
d) e) f) 
   g) 
Stratum corneum 
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Skin permeation and concentration-distance profiles under the infinite condition 
An in vitro skin permeation experiment was performed to further examine the permeation of FD-4 
through stripped pig ear skin. Skin permeation experiment was performed in three replicates.  Figure 7 
shows the time course of the cumulative amount of three individual profiles after topical application of 5 
mM FD-4 to the stripped pig ear skin. A typical lag time and subsequent steady state skin permeation were 
obtained. Furthermore, the profiles obtained in three samples were similar. The concentration-distance 
profile in the steady state period (5 h after starting the permeation experiment) was determined by the 
permeation parameters of FD-4 from skin permeation profiles using the difference equation based on the 
Fick’s 2nd law of diffusion as shown in the Methods in the subsection Theoretical (2). The calculated results 





































Figure 7. Time course of the cumulative amount of FD-4 that permeated through stripped pig ear skin. ●: sample A, 
: sample B, ▲: sample C 
 
Two samples were selected from the time courses of the cumulative amounts of FD-4 that permeated 
through the skin in order to investigate the skin concentration-distance profile of FD-4 in a non-steady 
state (lag time period). Dashed lines in Figure 9 show the concentration-distance profile obtained in the 
non-steady state (0.5 h), and these were calculated using the skin permeation parameters obtained from 
the permeation profile results in Figure 7. The results shown by the dashed lines in Figures 8 and 9 
suggested that the concentration-distance profiles of FD-4 in the stripped skin in the steady-state and 
before the steady-state could be determined from its permeation profiles using the difference equation 
based on the Fick’s law. 
 






































































































Figure 8. Concentration-distance profile of FD-4 in the steady state (5 h).  Symbols (○): Observed values from image 
analysis, Dashed line: Calculated value by the difference equation based on Fick’s law of diffusion from the skin 
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Figure 9. Concentration-distance profile of FD-4 in the non-steady state (0.5).  Symbols (□): Observed value from 
image analysis, Dashed line: Calculated value by the difference equation based on Fick’s law of diffusion from the skin 
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Imaging analysis by CLSM and comparison of concentration-distance profiles between observed and 
calculated values 
The intensity of fluorescence in the skin was measured by CLSM 0.5 and 5 h after starting the in vitro 
skin permeation experiment. Figures 10 and 11 show the images obtained of skin sections for the 
distribution of FD-4 5 and 0.5 h after the skin permeation experiment (in the steady and non-steady states, 
respectively). The intensity of fluorescence for FD-4 on the applied surface of the stripped pig ear skin was 
markedly high, while that at the receiver surface was unstable; therefore, it was difficult to quantify the 
intensity of fluorescence in these two surfaces. These surface intensities were subsequently omitted from 
the fluorescence analysis. Two images were randomly selected from the time courses of the cumulative 
amounts of FD-4. 
The concentration-distance profiles for FD-4 in the steady state (5 h) and non-steady state (0.5 h) were 
obtained from image analysis data by CLSM. Each point in Figures 8 and 9 shows the concentration of FD-4 
determined by CLSM imaging. The dashed lines in these figures were determined by skin permeation data, 
as described in (4. 3). The results obtained by CLSM were similar to those from the mathematical approach. 
These fluorescent gradients due to the permeation of FD-4 across the skin in both the steady state (5 h) 
and non-steady state (0.5 h) may be useful for visually understanding the concentration-distance profiles of 
chemical compounds across the skin. 
Discussion 
We used CLSM to quantitatively determine the skin concentration-distance profile of FD-4 at different 
depths through stripped skin. Limitations have been associated with the conventional methods used to 
determine drug concentration-distance profiles in the skin. CLSM could overcome these limitations 
because it generates high-resolution and sensitive images at multiple depths through the skin without the 
need for mechanical skin sections after the topical application of fluorescent drugs [29]. We applied a well-
established mathematical approach represented by the difference method based on Fick’s law of diffusion 
to obtain the skin concentration-distance profiles of topically applied drugs for comparisons in order to 
evaluate the present CLSM technique. A strong correlation (R2=0.99636) was observed between the 
intensity of fluorescence on CLSM images and the applied concentration of FD-4 (Fig. 6), which indicated 
that the intensity of fluorescence at each depth of the skin could be quantitatively evaluated by CLSM. 
Although few studies have determined the drug concentration-distance profiles of topically applied 
drugs, even less attention has been given to understanding the disposition behavior of these drugs through 
the skin under both steady-state and non-steady state conditions. Therefore, evaluating skin 
concentration-distance profiles is important under these conditions in order to address not only to efficacy, 
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Figure 10. CLSM images of FD-4 fluorescence intensity in stripped pig ear skin in the steady state (5 h) after the 
permeation experiment. a), b) and c) show samples A, B and C, respectively. Dashed line: boundary of the skin  
 
 
x = 0 x = Ltot
200 μm




Figure 11. CLSM images of FD-4 fluorescence intensity stripped pig ear skin in the non-steady state (0.5 h) after the 
permeation experiment. a) and b) show samples A and B, respectively. Dashed line: boundary of the skin 
 
Theoretical and observed FD-4 skin concentration-distance profiles were determined in both the steady 
and non-steady states in the present study. The theoretical and observed FD-4 concentration-distance 
profiles were almost equal at the steady and non-steady states (Figs. 8 and 9), which suggested that the 
concentration of the fluorescence compound may be precisely evaluated at multiple depths through skin 
using CLSM. Common artifacts include tearing, ripping, holes, and folding may occur during skin sectioning; 
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therefore, analysis points must be plotted to avoid such artifacts in order to calculate the fluorescent 
intensity for FD-4 from one skin section (Fig. 3). This could explain why slightly different skin concentration-
distance values were obtained for FD-4 between CLSM and the theoretical values (Figs. 8 and 9). 
Furthermore, plotted analysis points (25, 31, 37 and 43) (Fig. 3) were not selected as reference points to 
determine skin concentration-distance profiles due to the high intensity of FD-4 at the epidermis side. 
Plotted analysis points (30, 36, 42 and 48) (Fig. 3) at the dermis side were also not selected as reference 
points to determine skin concentration-distance profiles because they overlapped with the receiver 
compartment, which may lead to unclear images by CLSM. The present CLSM method provided a visual 
observation of drug distribution at multiple depths through the skin (Figs. 10 and 11) as an additional 
advantage over the mathematical approach. However, the intensity of fluorescence intensity was markedly 
high on the epidermis surface. Thus, it is necessary to carefully wash the fluorescence compound that is 
adsorbed on the skin surface. Further studies are needed to evaluate the distribution of FD-4 in skin 
sections cut laterally as well as through skin appendages such as hair follicles. We intend to use low 
molecular-weight fluorescence compounds in future studies. 
Conclusions 
The results of the present study clearly demonstrated that CLSM may be used to quantitatively 
determine the concentration-distance profiles of topically applied fluorescent drugs. These results provide 
a useful insight into dermatopharmacokinetics. 
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